https://arstechnica.com/science/2023/12/heres-how-the-first-fda-approved-crispr-therapy-works-to-treat-sickle-cell/
0
0
FDA approves first CRISPR therapy—here's how it works against sickle cell - Ars Technica
12/8/23 at 11:27pm
Organization
Ars Technica
Author
Beth Mole
Details
26 words
Summarize
Health Biological Sciences Pharmaceuticals & Biotech landmark treatment FDA Ars Technica sickling
The landmark treatment turns on another blood protein that prevents sickling.
Create an account or login to join the discussion